Interferon Gamma-1B
Signet Ring Adenocarcinoma of the Colon
National Cancer Institute (NCI)protein_peptidePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Signet Ring Adenocarcinoma of the Colon cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM University of Southern California | Phase 3 | BBB |
Calcium folinate pentahydrate University of Southern California | Phase 3 | BB |
Eloxatin John Hays | Phase 3 | BB |
Irinotecan Fox Chase Cancer Center | Phase 3 | BB |
Cetuximab National Cancer Institute (NCI) | Phase 2 | B |
View all 22 →
Same molecule, other indications
Interferon Gamma-1B is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →